Theravance Biopharma (TBPH) Tax Rate (2014 - 2026)

Theravance Biopharma's (TBPH) quarterly Tax Rate came in at 23.18% in Q1 2026, up 1923.0% year-on-year from 1.15% in Q1 2025, and down 48.63% on a QoQ basis from 45.13% in Q4 2025.

Theravance Biopharma (TBPH) Tax Rate (2014 - 2026) Analysis & Trends

Theravance Biopharma (TBPH) has 13 years of Tax Rate data on file, last reported at 23.18% in Q1 2026.

  • On a quarterly basis, Tax Rate rose 1923.0% year-over-year to 23.18% in Q1 2026; TTM through Mar 2026 was 29.24%, a 4988.0% increase from a year earlier, with the FY2025 full-year figure at 32.17%, up 5863.0% from the prior year.
  • Tax Rate for Q1 2026 stood at 23.18%, down from 45.13% in the prior quarter.
  • Over the last five years, Tax Rate for TBPH reached as high as 225.13% in Q3 2025 and fell as low as 73.7% in Q4 2024.
  • Historically, Tax Rate has averaged 10.08% across 5 years, with a median of 0.02% in 2022.
  • Across the five-year window, Tax Rate plunged 6798 bps in 2024 and jumped 25145 bps in 2025, its largest moves.
  • Year by year, Tax Rate stood at 0.02% in 2022, then tumbled by 27295 bps to 5.72% in 2023, then plunged by 1188 bps to 73.7% in 2024, then jumped by 161 bps to 45.13% in 2025, then plunged by 49 bps to 23.18% in 2026.
  • Per Business Quant data, the three most recent Tax Rate figures were 23.18% in Q1 2026, 45.13% in Q4 2025, and 225.13% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Tax Rate (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -0.34%
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 12.29%
4 NuCana 279.75 Bn 279.75 Bn - -5.41%
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 17.68%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 12.51%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 33.09%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Theravance Biopharma 864.56 Mn 469.90 Mn - 23.18%

Historic Data

Download Data
DateValue
Mar 31, 2026 23.18%
Mar 31, 2026 23.18%
Mar 31, 2026 23.18%
Dec 31, 2025 45.13%
Dec 31, 2025 45.13%
Dec 31, 2025 45.13%
Sep 30, 2025 225.13%
Sep 30, 2025 225.13%
Sep 30, 2025 225.13%
Jun 30, 2025 25.09%
Jun 30, 2025 25.09%
Jun 30, 2025 25.09%
Mar 31, 2025 3.95%
Mar 31, 2025 3.95%
Mar 31, 2025 3.95%
Dec 31, 2024 -73.70%
Dec 31, 2024 -73.70%
Dec 31, 2024 -73.70%
Sep 30, 2024 -26.32%
Sep 30, 2024 -26.32%